By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel is divided on BXMT, with concerns about rate sensitivity and office exposure outweighing potential value and dividend yield.
Risk: Rate sensitivity and potential credit migration in the office portfolio could evaporate dividend coverage.
Opportunity: Potential re-rating if Fed cuts materialize, given BXMT's portfolio stabilization and resilient sectors.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Chicago-based Cura Wealth Advisors sold 155,210 shares of BXMT in the first quarter; the estimated trade size was $2.99 million (based on quarterly average prices).
Meanwhile, the quarter-end position value declined by $2.97 million, reflecting share sale and price change.
The move represents a 1.34% change in 13F reportable assets under management.
Post-sale, Cura held 32,300 BXMT shares valued at $618,545.
On May 8, 2026, Chicago-based Cura Wealth Advisors disclosed in a Securities and Exchange Commission filing that it sold 155,210 shares of Blackstone Mortgage Trust (NYSE:BXMT), with the estimated transaction value at $2.99 million based on quarterly average pricing.
According to a filing with the Securities and Exchange Commission dated May 8, 2026, Cura Wealth Advisors reduced its holdings in Blackstone Mortgage Trust by 155,210 shares. The estimated value of shares sold was $2.99 million, calculated using the average closing price for the quarter. The value of the position at quarter-end fell by $2.97 million, reflecting both the trade and market movement.
NYSEMKT:VT: $5.57 million (2.5% of AUM)
As of May 7, 2026, BXMT shares were priced at $19.15, roughly flat over the past year and underperforming the S&P 500, which is instead up about 30%.
| Metric | Value | |---|---| | Revenue (TTM) | $585.1 million | | Net income (TTM) | $103.63 million | | Dividend yield | 9.82% | | Price (as of market close May 7, 2026) | $19.15 |
Blackstone Mortgage Trust is a leading mortgage REIT focused on originating and managing senior commercial real estate loans globally.
Blackstone Mortgage Trust’s latest earnings report showed a mixed picture that might explain why a wealth advisory like Cura would choose to trim its stake. BXMT posted a first-quarter net loss of $6.3 million, or $0.04 per share, though distributable EPS prior to realized gains and losses came in at $0.49 per share, slightly above the company’s $0.47 dividend. Management emphasized that 98% of the loan portfolio remains performing, with more than half tied to residential and industrial properties rather than office buildings. The firm also maintained roughly $1 billion in liquidity and no corporate debt maturities until 2027.
But even though Blackstone Mortgage Trust has stabilized considerably from the worst of the office-property fears, the stock has still badly lagged the broader market, and some investors may simply be losing patience waiting for sentiment to recover. The nearly 9.4% annualized dividend yield is attractive, but mortgage REITs remain highly sensitive to interest rates, property values, and refinancing conditions, all of which long-term investors should keep in mind.
Before you buy stock in Blackstone Mortgage Trust, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Blackstone Mortgage Trust wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $471,827! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,319,291!
Now, it’s worth noting Stock Advisor’s total average return is 986% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 10, 2026. *
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie and Abbott Laboratories. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The narrowing spread between distributable EPS and dividend payouts, combined with persistent commercial real estate headwinds, makes BXMT a high-risk yield trap rather than a value play."
Cura Wealth’s trimming of BXMT is a classic 'yield-trap' exit. While the 9.8% dividend yield looks enticing, the $6.3 million net loss highlights the underlying fragility of the commercial mortgage REIT model in a 'higher-for-longer' rate environment. BXMT is essentially a levered bet on office-space stabilization; with the stock flatlining while the S&P 500 rallies 30%, the opportunity cost is becoming prohibitive. Investors are essentially paying for a dividend that is barely covered by distributable EPS, leaving zero margin for error if credit spreads widen or further office impairments hit the book value.
The thesis against this is that BXMT’s 98% performing loan portfolio and $1 billion liquidity buffer provide a sufficient floor to survive the cycle, potentially setting up a massive valuation re-rating once the Fed finally pivots to sustained rate cuts.
"Cura's tiny trim ignores BXMT's fortified fundamentals and high yield at a deep book discount, making it a buy for patient income seekers."
Cura's $3M BXMT sale—shrinking a 1.4% AUM position to 0.28%—is negligible noise from a small advisor, not a canary in the coal mine. BXMT's Q1 distributable EPS ($0.49) covered its $0.47 dividend handily, with 98% performing loans skewed to resilient resi/industrial (not office-heavy), $1B liquidity, and no corporate maturities until 2027. At $19.15, the 9.8% yield and ~0.85x book value discount scream value vs. peers like FSK/MFIC (which Cura still favors). Flat stock masks mREIT sensitivity to rates, but portfolio stabilization positions it for re-rating if Fed cuts materialize.
Commercial real estate could see broader contagion if office distress spreads to industrial amid slowing growth, eroding BXMT's book value and forcing dividend cuts despite current coverage.
"BXMT's 9.8% yield is a value trap if Fed rate cuts materialize, as lower rates compress origination spreads and reduce refinancing demand—the article never addresses this rate-path dependency."
This article conflates a micro-level portfolio rebalance with macro thesis on BXMT. Cura's $3M sale is noise—the fund went from 1.4% to 0.28% of AUM, suggesting a mechanical trim rather than conviction-driven exit. More telling: BXMT's 9.82% yield, flat stock price, and 98% performing loans suggest the market has already priced in office risk. The real issue is rate sensitivity. If the Fed cuts rates materially, BXMT's origination spreads compress and refinancing becomes cheaper for borrowers—both headwinds. The article ignores this entirely.
BXMT's distributable EPS of $0.49 exceeds its $0.47 dividend with room to spare, and the firm has $1B liquidity with no debt maturities until 2027—suggesting the dividend is genuinely safe and undervalued at current multiples if rates stabilize.
"The Cura BXMT sale is a micro, tactical move with little signal about BXMT's fundamentals; the bigger risks are macro rate dynamics and CRE refinancing, not this one-off 13F trade."
What stands out is how modest Cura's BXMT sale is: 155,210 shares for roughly $3 million, shrinking a position that was only 0.28% of Cura’s 13F assets. That’s micro-capital, not a verdict on BXMT. The article ties the move to office stress and lagging stock performance, but context matters: 13F data is stale, and this is a quarterly rebalancing, not a bet on BXMT’s earnings quality. BXMT’s Q1 net loss of $0.04 per share contrasts with $0.49 distributable EPS and a hefty 9.8% dividend yield; plus liquidity around $1 billion and no maturities before 2027, which mitigates immediate funding risk. The missing piece: BXMT’s TBV/NAV trajectory and how rate moves affect dividend coverage.
Yet this could be more than noise: if more 13Fs trim mortgage REITs in coming quarters, it would signal a secular reweighting away from rate‑sensitive CRE lenders; the article glosses over potential NAV compression and distribution sustainability under higher-for-longer rates.
"BXMT's dividend coverage is structurally threatened by potential net interest margin compression if the Fed cuts rates."
Claude, you’re missing the structural risk: BXMT’s floating-rate loan book is a double-edged sword. While rate cuts help borrower solvency, they directly compress net interest income because BXMT’s cost of capital remains sticky. If the Fed pivots, the dividend coverage you’re betting on could evaporate as spreads tighten. The 'value' argument ignores that book value is still vulnerable to credit migration in the office portfolio, which remains the primary catalyst for potential dividend cuts.
"BXMT's floating liability-asset match preserves NII spreads on Fed cuts, with low office exposure amplifying value at 0.85x book."
Gemini, NII compression from rate cuts assumes sticky funding costs, but BXMT's liabilities are ~85% floating-rate (SOFR-tied repos/credit facilities) that reprice downward in tandem with assets—spreads hold. Office exposure is just 12% of portfolio per Q1; resi/industrial (60%+) benefits from cuts via cap rates. Unmentioned: peer mREITs like AGNC trading at premiums signal BXMT's 0.85x BVX mispricing.
"BXMT's funding cost stability breaks down in a credit stress scenario, not just rate cuts."
Grok's 85% floating-rate liability argument needs stress-testing: repo funding costs don't move 1:1 with SOFR during credit events. If office contagion widens spreads, BXMT faces higher repo haircuts and rollover risk even if SOFR falls. The 12% office exposure is also understated—it's concentrated in distressed metros (NYC, SF) where cap-rate compression accelerates losses. Peer premiums (AGNC) reflect portfolio quality, not BXMT's specific risk.
"Floating-rate liabilities do not guarantee BXMT a dividend floor—spread volatility and NAV risk from office CRE can erode coverage before 2027 debt maturities."
Grok's claim of 85% floating-rate liabilities reprice 'in tandem' with assets is optimistic. In a spread-widening CRE stress, repo haircuts and refinancing risk can blow out even as rates fall. The 12% office exposure in distressed metros and potential NAV pressure from credit losses could erode dividend coverage long before 2027 maturities. BXMT's rate sensitivity remains a real cliff, not a floor.
The panel is divided on BXMT, with concerns about rate sensitivity and office exposure outweighing potential value and dividend yield.
Potential re-rating if Fed cuts materialize, given BXMT's portfolio stabilization and resilient sectors.
Rate sensitivity and potential credit migration in the office portfolio could evaporate dividend coverage.